top of page

Efficient selection of tumor associated neoantigens in the design of personalized cancer vaccines
Michael Princiotta, CSO EpiVax Therapeutics

International Society for Vaccines (ISV) Annual Meeting

September 2021

Subscribe Form

Thanks for submitting!

  • LinkedIn
  • YouTube

©2023 by EpiVax Therapeutics, Inc.

bottom of page